High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil

High emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant women submitted to antiretroviral treatment to prevent mother-to-child transmission in Rio de Janeiro, Brazil

Bibliographic Details
Main Authors:	Ismerio Ronaldo, Muri Sandra, Khalili Ruth, Ribeiro Jorge Eurico, Velasco-de-Castro Carlos Augusto, Rodrigues-Pedro Adriana, Couto-Fernandez Jose Carlos, Veloso Valdilea, Grinsztejn Beatriz, Pilotto Jose Henrique, Courrier Judith, Morgado Mariza G
Format:	Article
Language:	English
Published:	BMC 2009-07-01
Series:	Retrovirology

Similar Items

Assessing the emergence of drug resistance in a cohort of HIV infected pregnant women under HAART for prophylaxis of mother-to-child transmission (MTCT) followed in a referral center in Rio de Janeiro, Brazil
by: Ismerio Ronaldo, et al.
Published: (2008-04-01)

Anti-human immunodeficiency virus type 1 humoral immune response and highly active antiretroviral treatment
by: Vera Bongertz, et al.
Published: (2007-11-01)

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.
by: Jose Manuel Vazquez-Guillen, et al.
Published: (2016-01-01)

Prevalence, estimated HIV-1 incidence and viral diversity among people seeking voluntary counseling and testing services in Rio de Janeiro, Brazil
by: Bastos Francisco I, et al.
Published: (2010-07-01)

Tolerability of antiretroviral therapy (HAART) in elderly age
by: Celesia B M
Published: (2010-05-01)

HIV-1 diversity and drug resistance mutations among people seeking HIV diagnosis in voluntary counseling and testing sites in Rio de Janeiro, Brazil.
by: Carlos A Velasco-de-Castro, et al.
Published: (2014-01-01)

Towards an ideal antiretroviral regimen for the global HIV epidemic
by: Beatriz Grinsztejn, et al.
Published: (2017-07-01)

Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
by: Redfield Robert, et al.
Published: (2006-12-01)

Incidence of antiretroviral adverse drug reactions in pregnant women in two referral centers for HIV prevention of mother-to-child-transmission care and research in Rio de Janeiro, Brazil
by: Marilia Santini-Oliveira, et al.
Published: (2014-07-01)

Factors that influence adherence to highly active antiretroviral therapy (HAART).
by: Naicker, Michaela Helene.
Published: (2013)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
by: Sinha Rajesh, et al.
Published: (2008-01-01)

HIV-specific CD8+ T cell responses in infected infacts enrolled on a study of early highly active antiretroviral treatment (HAART) and supervised treatment interruption (STI).
by: Thobakgale, Christina Fanesa.
Published: (2012)

Interruption of antiretroviral treatment in HIV-infected children
by: Gerlach, Undine Ariane
Published: (2004)

Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
by: Hamilton Domingos, et al.

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba, et al.
Published: (2012-01-01)

Behavioral Characteristics of Adult Patients on Highly Active Antiretroviral Therapy (HAART) in Uganda
by: Constance Shumba
Published: (2012-01-01)

The impact of in-utero highly active antiretroviral therapy (HAART) exposure on infant outcomes
by: Van der Merwe, Karin Joan
Published: (2011)

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil.
by: Guilherme Amaral Calvet, et al.
Published: (2014-01-01)

Ocular problems in brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era
by: Marcia Lopes Rodrigues, et al.

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Incidence rate of modifying or discontinuing first combined antiretroviral therapy regimen due to toxicity during the first year of treatment stratified by age
by: Thiago Silva Torres, et al.
Published: (2014-01-01)

Impact of highly active antiretroviral therapy (HAART) on clinical outcomes of vertically HIV-1 infected children
by: Muñoz-Fernandez MªÁngeles, et al.
Published: (2008-04-01)

Lipodystrophy in Human Immunodeficiency Virus (HIV) Patients on Highly Active Antiretroviral Therapy (Haart)
by: N. Sunil Kumar, et al.
Published: (2015-07-01)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
by: Dereudre-Bosquet Nathalie, et al.
Published: (2009-09-01)

The impact of Highly Active Antiretroviral Therapy (HAART) on perceived health and labour supply in Khayelitsha
by: Coetzee, Celeste
Published: (2014)

Kepatuhan pesakit HIV positif terhadap rawatan Highly Active Antiretroviral Therapy (HAART)
by: Najwa Afiqa Roshaizad, et al.
Published: (2020)

Predictors of SIV recrudescence following antiretroviral treatment interruption
by: Mykola Pinkevych, et al.
Published: (2019-10-01)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018-06-01)

Treinamento físico para indivíduos HIV positivo submetidos à HAART: efeitos sobre parâmetros antropométricos e funcionais Physical training for HIV positive individuals submitted to HAART: effects on anthropometric and functional parameters
by: Edmar Lacerda Mendes, et al.
Published: (2013-02-01)

Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
by: Amanda Rodrigues, et al.
Published: (2021-02-01)

Cascade of access to interventions to prevent HIV mother to child transmission in the metropolitan area of Rio de Janeiro, Brazil
by: Elaine S. Pires Araujo, et al.
Published: (2014-05-01)

Breast cancer in a cohort of human immunodeficiency virus (HIV)-infected women from Rio de Janeiro, Brazil: a cases series report and an incidence rate estimate
by: Angela Cristina Vasconcelos de Andrade, et al.

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

Correction to: Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment
by: Amanda Rodrigues, et al.
Published: (2021-04-01)

Effectiveness of antiretroviral therapy (haart) In hiv positive patients admitted to the treatment Program of “atencion integral ips” in the city of Cartagena. Colombia
by: Torres-Mora Gustavo, et al.
Published: (2011-06-01)

Prevalence of depressive symptoms amongst highly active antiretroviral therapy (HAART) patients in AIDSRelief Uganda
by: Constance Shumba, et al.
Published: (2013-11-01)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
by: Palermo F, et al.
Published: (2010-05-01)

Long-term CD4+ cell count in response to combination antiretroviral therapy.
by: Paula M Luz, et al.
Published: (2014-01-01)

Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.
by: Kathy Lawler, et al.
Published: (2011-02-01)